This announcement is a separate document:
君實生物：自願性公告－特瑞普利單抗聯合貝伐珠單抗一線治療晚期肝細胞癌的新適應症上市申請獲得受理
JUNSHI BIO: VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL NEW DRUG APPLICATION FOR TORIPALIMAB IN COMBINATION WITH BEVACIZUMAB FOR THE FIRST-LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated